HTML from...
URL: https://open.canada.ca/data/en/dataset/86f833f9-7b99-462a-bcce-0fc71cd2f829
Health Canada has notified Jennewein Biotechnologie, GmbH, that it has no objection to the use of 2'-fucosyllactose (2'-FL) derived from a genetically modified strain of E. coli BL21 (DE3), "the production strain" or "the strain", as an ingredient for infant formula. The Department conducted a comprehensive assessment of this oligosaccharide according to its Guidelines for the Safety Assessment of Novel Foods.
Il n'y a encore aucune visualisation créée pour cette ressource
Informations additionnelles
| Champ | Valeur |
|---|---|
| Dernière modification de la donnée | 16 janvier 2026 |
| Dernière modification de la métadonnée | 16 janvier 2026 |
| Créé le | 16 janvier 2026 |
| Format | HTML |
| Licence | License not specified |
| Datastore active | False |
| Has views | False |
| Id | dd8613bb-938f-4a4c-ac73-fc67de8cc655 |
| Package id | 6dddde0b-3a86-4a42-b460-317fd5498903 |
| Position | 0 |
| State | active |